Company intelligence / Profile preview

Torrey Pines Asset Management

San Diego, California, United Statestorreypinespm.com ↗

Ownership: Private
Development stage: Other

Overview

Torrey Pines Investment supports early-stage biopharma and diagnostic companies across CNS, oncology, virology, and women’s health. Their portfolio includes assets from preclinical to Phase II. Notable results include Viriom completing Phase I trials for AV5124 for influenza treatment; Leap advancing DKN‑01 into Phase II gastric cancer studies. They focus on value creation through pharma partnering/M&A.[1][4][6]

Therapeutic areas: OtherOncologyNeurologyInfectious Diseases
Modalities: Small moleculeBiologicDrug-deviceImmunotherapyDiagnostic
Industry: Investors

Partnerships

Pharma partners via M&A exits or co-development dealsi2020 Accelerator program partnerships

Beyond the preview

Go deeper on Torrey Pines Asset Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Torrey Pines Asset Management.

Explore the full profile